Semiconductors Healthcare Sector

Tectonic Therapeutic

Market Cap: US$386.5m

A clinical stage biotechnology company focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G-protein-coupled receptors (GPCRs).

ORIC Pharmaceuticals

Market Cap: US$384.6m

A clinical-stage biopharmaceutical company, engages in the discovery and development of therapies to counter the resistance mechanisms cancers in the United States.

Semler Scientific

Market Cap: US$382.5m

Provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States.

Cytek Biosciences

Market Cap: US$382.5m

A cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications.

Rapport Therapeutics

Market Cap: US$382.1m

Operates as a clinical-stage biopharmaceutical company that focuses on the discovery and development of transformational small molecule medicines for patients suffering from central nervous system (CNS) disorders.

ClearPoint Neuro

Market Cap: US$381.6m

Operates as a medical device company primarily in the United States.

TruBridge

Market Cap: US$381.5m

Provides healthcare solutions and services for community hospitals, clinics, and other healthcare systems in the United States and internationally.

Organogenesis Holdings

Market Cap: US$378.7m

A regenerative medicine company, develops, manufactures, and commercializes products for the advanced wound care, and surgical and sports medicine markets in the United States.

Alpha Teknova

Market Cap: US$377.3m

Produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally.

Verastem

Market Cap: US$375.4m

A development-stage biopharmaceutical company, focuses on developing and commercializing drugs for the treatment of cancer in the United States.

Absci

Market Cap: US$373.7m

Operates as a data-first generative artificial intelligence (AI) drug creation company in the United States.

MBX Biosciences

Market Cap: US$372.3m

A clinical-stage biopharmaceutical company, focuses on the discovery and development of precision peptide therapies for the treatment of endocrine and metabolic disorders.

Oruka Therapeutics

Market Cap: US$365.0m

A clinical-stage biopharmaceutical company, focuses on developing novel monoclonal antibody therapeutics for psoriasis (PsO), and other inflammatory and immunology (I&I) indications.

Faron Pharmaceuticals Oy

Market Cap: UK£274.2m

Operates as a clinical stage drug discovery and development company.

Claritev

Market Cap: US$364.8m

Provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States.

COMPASS Pathways

Market Cap: US$363.0m

Operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States.

NIOX Group

Market Cap: UK£270.1m

Engages in the design, development, and commercialization of medical devices for asthma diagnosis, monitoring, and management worldwide.

Autolus Therapeutics

Market Cap: US$359.3m

A clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer and autoimmune diseases in United Kingdom and internationally.

Clinuvel Pharmaceuticals

Market Cap: AU$555.1m

A biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally.

SBC Medical Group Holdings

Market Cap: US$359.0m

Engages in the provision of management services to cosmetic treatment centers in Japan, Vietnam, the United States, and internationally.

Cryoport

Market Cap: US$358.5m

Provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide.

Mayne Pharma Group

Market Cap: AU$551.7m

A specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe, Asia, and internationally.

Nano-X Imaging

Market Cap: US$354.5m

Develops a commercial-grade tomographic imaging device with a digital X-ray source.

Zhengye Biotechnology Holding

Market Cap: US$351.2m

Engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in China.

Checkpoint Therapeutics

Market Cap: US$348.5m

A commercial -stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers in the United States and internationally.

SNDL

Market Cap: US$339.6m

Engages in the production, distribution, and sale of cannabis products in Canada.

TurnKey Capital

Market Cap: US$338.5m

HealthSpan Medical Systems, Inc. develops marijuana based intravenous therapy (IV) infusion blends for healthcare practitioners.

Benitec Biopharma

Market Cap: US$335.0m

A clinical-stage biotechnology company, focuses on the development of novel genetic medicines.

Pacific Biosciences of California

Market Cap: US$330.1m

Designs, develops, and manufactures sequencing solution to resolve genetically complex problems.

Rigel Pharmaceuticals

Market Cap: US$326.9m

A biotechnology company, engages in discovering, developing, and providing therapies that enhance the lives of patients with hematologic disorders and cancer.

Olema Pharmaceuticals

Market Cap: US$325.4m

A clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women’s cancers.

Capricor Therapeutics

Market Cap: US$324.8m

A clinical-stage biotechnology company, engages in the development of transformative cell and exosome-based therapeutics for treating duchenne muscular dystrophy (DMD) and other diseases with unmet medical needs in the United States.

Emergent BioSolutions

Market Cap: US$317.3m

A life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States.

Cresco Labs

Market Cap: CA$439.8m

Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States.

National Research

Market Cap: US$315.6m

Provides analytics and insights that facilitate measurement and improvement of the patient and employee experience.

Health Catalyst

Market Cap: US$314.6m

Provides data and analytics technology and services to healthcare organizations in the United States.